Effect of shock wave treatment on platelet-rich plasma added to osteoblast cultures

Ultrasound in Medicine and Biology

Volumn 37, Issue 1, 2011, Pages 160-168

  Notarnicola, Angela ^a   Tamma, Roberto ^b   Moretti, Lorenzo ^a   Panella, Antonio ^a   Dell'Endice, Stefania ^b   Zallone, Alberta ^b   Moretti, Biagio ^a,b,c  

^a UNIVERSITY OF BARI MEDICAL SCHOOL   (Italy)

^b UNIVERSITY OF BARI   (Italy)

^c SITOD   (Italy)

Author keywords

Osteogenesis; Platelet rich plasma; Shockwaves

Indexed keywords

COLLAGEN TYPE I; ENERGY FLOW DENSITY; GERMANY; GROWTH FACTOR; IGFBP-3; INSULIN-LIKE GROWTH FACTOR; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; OSTEOBLAST CULTURES; OSTEOCALCIN; OSTEOGENESIS; PLATELET-RICH PLASMA; PROTEIN SYNTHESIS; REAL-TIME PCR; SHOCK WAVE TREATMENTS; ULTRASOUND IN MEDICINE; WESTERN BLOTTING;

INSULIN; OSTEOBLASTS; PEPTIDES; PLASMAS; POLYMERASE CHAIN REACTION; SHOCK WAVES; TRANSCRIPTION FACTORS; WAVES;

PLATELETS;

COLLAGEN TYPE 1; OSTEOCALCIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; BONE DEVELOPMENT; CELL ACTIVITY; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STIMULATION; CONTROLLED STUDY; EXTRACORPOREAL LITHOTRIPSY; MOUSE; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; THROMBOCYTE RICH PLASMA; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CORE BINDING FACTOR ALPHA 1 SUBUNIT; HIGH-INTENSITY FOCUSED ULTRASOUND ABLATION; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MICE; MICE, INBRED C57BL; OSTEOBLASTS; PLATELET-RICH PLASMA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 78649904550     PISSN: 03015629     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ultrasmedbio.2010.10.016     Document Type: Article

References (60)

1. Aicher A., Heeschen C., Sasaki K., Urbich C., Zeiher A.M., Dimmeler S. Low-energy shock wave for enhancing recruitment of endothelial progenitor cells. A new modality to increase efficacy of cell therapy in chronic hind limb ischemia. Circulation 2006, 114:2823-2830.
2. Alliston T., Choy L., Ducy P., Karsenty G., Derynck R. TGF-beta-induced repression of CBFA1 by Smad3 decreases cbfa1 and osteocalcin expression and inhibits osteoblast differentiation. EMBO J 2001, 20:2254-2272.
3. Anitua E., Andia I., Ardanza B., Nurden P., Nurden A.T. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 2004, 91:4-15.
4. Binkert C., Landwehr J., Mary J.L., Schwander J., Heinrich G. Cloning, sequence analysis and expression of a cDNA encoding a novel insulin-like growth factor binding protein (IGFBP-2). EMBO J 1989, 8:2497-2502.
5. Camarda A.J., Butler W.T., Finkelman R.D., Nanci A. Immunocytochemical localization of gamma-carboxyglutamic acid-containing proteins (osteocalcin) in rat bone and dentin. Calcif Tissue Int 1987, 40:349-355.
6. Canalis E., Centrella M., Burch W., McCarthy T.L. Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest 1989, 83:60-65.
7. Chen Y.J., Wurtz T., Wang C.J., Kuo Y.R., Yang K.D., Huang H.C., Wang F.S. Recruitment of mesenchymal stem cells and expression of TGF-beta 1 and VEGF in the early stage of shock wave-promoted bone regeneration of segmental defect in rats. J Orthop Res 2004, 22:526-534.
8. Chung B., Wiley J.P. Extracorporeal shockwave therapy. Sports Med 2002, 32:851-865.
9. Ducy P., Karsenty G. Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 1995, 15:1858-1869.
10. Ducy P., Zhang R., Geoffroy V., Ridall A.L., Karsenty G. Osf2/Cbfa1: A transcriptional activator of osteoblast differentiation. Cell 1997, 89:747-754.
11. Foster T.E., Puskas B.L., Mandelbaum B.R., Gerhardt M.B., Rodeo S.A. Platelet-rich plasma: From basic science to clinical applications. Am J Sports Med 2009, 37:2259-2272.
12. Frolik C.A., Ellis L.F., Williams D.C. Isolation and characterization of insulin-like growth factor-II from human bone. Biochem Biophys Res Commun 1988, 151:1011-1018.
13. Gandhi A., Doumas C., O'Connor J.P., Parsons J.R., Lin S.S. The effects of local platelet rich plasma delivery on diabetic fracture healing. Bone 2006, 38:540-546.
14. Gazzerro E., Canalis E. Bone morphogenetic proteins and their antagonists. Rev Endocrinol Metab Disord 2006, 7:51-65.
15. Hakki S.S., Bozkurt B.S., Hakki E.E. Boron regulates mineralized tissue-associated proteins in osteoblasts. J Trace Elem Med Biol 2010 Aug 2, (in press).
16. Harrison P., Cramer E.M. Platelet alpha-granules. Blood Rev 1993, 7:52-62.
17. Hausdorf J., Sievers B., Schmitt-Sody M., Jansson V., Maier M., Mayer-Wagner S. Stimulation of bone growth factor synthesis in human osteoblasts and fibroblasts after extracorporeal shock wave application. Arch Orthop Trauma Surg 2010 Aug 22, (in press).
18. Ho C. Extracorporeal shock wave treatment for chronic plantar fasciitis (heel pain). Issues Emerg Health Technol 2007, 96:1-4.
19. Hong J., Zhang G., Dong F., Rechler M.M. Insulin-like growth factor (IGF)-binding protein-3 mutants that do not bind IGF-I or IGF-II stimulate apoptosis in human prostate cancer cells. J Biol Chem 2002, 277:10489-10497.
20. Javed A., Guo B., Hiebert S., Choi J.Y., Green J., Zhao S.C., Osborne M.A., Stifani S., Stein J.L., Lian J.B., van Wijnen A.J., Stein G.S. Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription. J Cell Sci 2000, 113:2221-2231.
21. Jeon H.B., Sayre L.M. Highly potent propargylamine and allylamine inhibitors of bovine plasma amine oxidase. Biochem Biophys Res Commun 2003, 304:788-794.
22. Johnson G.W., Cadwallader K., Scheffel S.B., Epperly T.D. Treatment of lateral epicondylitis. Am Fam Physician 2007, 76:843-848.
23. Jones J.I., Clemmons D.R. Insulin-like growth factors and their binding proteins: Biological actions. Endocrinol Rev 1995, 16:3-34.
24. Kearney R., Costa M.L. Insertional Achilles tendinopathy management: A systematic review. Foot Ankle Int 2010, 31:689-694.
25. Kern B., Shen J., Starbuck M., Karsenty G. Cbfa1 contributes to the osteoblast-specific expression of type I collagen genes. J Biol Chem 2001, 276:7101-7107.
26. Kiefer M.C., Masiarz F.R., Bauer D.M., Zapf J. Identification and molecular cloning of two new 30-kDa insulin-like growth factor binding proteins isolated from adult human serum. J Biol Chem 1991, 266:9043-9049.
27. Komori T. Runx2, a multifunctional transcription factor in skeletal development. J Cell Biochem 2002, 87:1-8.
28. LaTour D., Mohan S., Linkhart T.A., Baylink D.J., Strong D.D. Inhibitory insulin-like growth factor-binding protein: cloning, complete sequence, and physiological regulation. Mol Endocrinol 1990, 4:1806-1814.
29. Lee P.D., Hintz R.L., Rosenfeld R.G., Benitz W.E. Presence of insulinlike growth factor receptors and lack of insulin receptors on fetal bovine smooth muscle cells. Vitro Cell Dev Biol 1988, 24:921-926.
30. Lemmey A.B., Glassford J., Flick-Smith H.C., Holly J.M., Pell J.M. Differential regulation of tissue insulin-like growth factor-binding protein (IGFBP)-3, IGF-I and IGF type 1 receptor mRNA levels, and serum IGF-I and IGFBP concentrations by growth hormone and IGF-I. J Endocrinol 1997, 154:319-328.
31. Liu Y., Kalen A., Risto O., Wahlström O. Fibroblast proliferation due to exposure to a platelet concentrate in vitro is pH dependent. Wound Repair Regen 2002, 10:336-340.
32. Longobardi L., Torello M., Buckway C., O'Rear L., Horton W.A., Hwa V., Roberts C.T., Chiarelli F., Rosenfeld R.G., Spagnoli A. A novel insulin-like growth factor (IGF)-independent role for IGF binding protein-3 in mesenchymal chondroprogenitor cell apoptosis. Endocrinology 2003, 144:1695-1702.
33. Mariotto S., Cavalieri E., Amelio E., Ciampa A.R., de Prati A.C., Marlinghaus E., Russo S., Suzuki H. Extracorporeal shock waves: From lithotripsy to anti-inflammatory action by NO production. Nitric Oxide 2005, 12:89-96.
34. Martini L., Giavaresi G., Fini M., Torricelli P., Borsari V., Giardino R., De Pretto M., Remondini D., Castellani G.C. Shock wave therapy as an innovative technology in skeletal disorders: Study on transmembrane current in stimulated osteoblast-like cells. Int J Artif Organs 2005, 28:841-847.
35. Miyakoshi N., Richman C., Kasukawa Y., Linkhart T.A., Baylink D.J., Mohan S. Evidence that IGF-binding protein-5 functions as a growth factor. J Clin Invest 2001, 107:73-81.
36. Mohan S., Jennings J.C., Linkhart T.A., Baylink D.J. Primary structure of human skeletal growth factor: Homology with human insulin-like growth factor-II. Biochim Biophys Acta 1988, 966:44-55.
37. Mukherjee A., Rotwein P. Insulin-like growth factor-binding protein-5 inhibits osteoblast differentiation and skeletal growth by blocking insulin-like growth factor actions. Mol Endocrinol 2008, 22:1238-1250.
38. Murata R., Nakagawa K., Ohtori S., Ochiai N., Arai M., Saisu T., Sasho T., Takahashi K., Moriya H. The effects of radial shock waves on gene transfer in rabbit chondrocytes in vitro. Osteoarthr Cartilage 2007, 15:1275-1282.
39. Niu T., Rosen C.J. The insulin-like growth factor-I gene and osteoporosis: A critical appraisal. Gene 2005, 361:38-56.
40. Ogden J.A., To'th-Kischkat A., Reiner S. Principles of shock wave therapy. Clin Orthop Relat Res 2001, 387:8-17.
41. Ohlsson C., Bengtsson B.A., Isaksson O.G., Andreassen T.T., Slootweg M.C. Growth hormone and bone. Endocrinol Rev 1998, 19:55-79.
42. Owen T.A., Aronow M., Shalhoub V., Barone L.M., Wilming L., Tassinari M.S., Kennedy M.B., Pockwinse S., Lian J.B., Stein G.S. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 1990, 143:420-430.
43. Pfaffl M.W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001, 29:e45.
44. Ranly D.M., Lohmann C.H., Andreacchio D., Boyan B.D., Schwartz Z. Platelet-rich plasma inhibits demineralized bone matrix-induced bone formation in nude mice. J Bone Joint Surg Am 2007, 89:139-147.
45. Rebuzzi E., Coletti N., Schiavetti S., Giusto F. Arthroscopy surgery versus shock wave therapy for chronic calcifying tendinitis of the shoulder. J Orthop Traumatol 2008, 9:179-185.
46. Richman C., Baylink D.J., Lang K., Dony C., Mohan S. Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. Endocrinology 1999, 140:4699-4705.
47. Rompe J.D., Krischek O., Eysel P., Hopf C. Chronische insertionstendpathie am lateralen epicondylus humeri-Ergebnisse der extrakorporalen strosswellenapplikation. Schmerz 1998, 12:105-111.
48. Shimasaki S., Shimonaka M., Zhang H.P., Ling N. Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP-5 in rat and human. J Biol Chem 1991, 266:10646-10653.
49. Simman R., Hoffmann A., Bohinc R.J., Peterson W.C., Russ A.J. Role of platelet-rich plasma in acceleration of bone fracture healing. Ann Plast Surg 2008, 61:337-344.
50. Smith S.E., Roukis T.S. Bone and wound healing augmentation with platelet-rich plasma. Clin Podiatr Med Surg 2009, 26:559-588.
51. Sugioka K., Nakagawa K., Murata R., Ochiai N., Sasho T., Arai M., Tsuruoka H., Ohtori S., Saisu T., Gemba T., Takahashi K. Radial shock waves effectively introduced NF-kappa B decoy into rat Achilles tendon cells in vitro. J Orthop Res 2010, 28:1078-1083.
52. Tamma R., dell'Endice S., Notarnicola A., Moretti L., Patella S., Patella V., Zallone A., Moretti B. Extracorporeal shock waves stimulate osteoblast activities. Ultrasound Med Biol 2009, 35:2093-2100.
53. van Leeuwen M.T., Zwerver J., van den Akker-Scheek I. Tendinopathy: A review of the literature, Extracorporeal shockwave therapy for patellar. Br J Sports Med 2009, 43:163-168.
54. Vulpiani M.C., Vetrano M., Savoia V., Di Pangrazio E., Trischitta D., Ferretti A. Jumper's knee treatment with extracorporeal shock wave therapy: A long-term follow-up observational study. J Sports Med Phys Fitness 2007, 47:323-328.
55. Wada T., Nakashima T., Hiroshi N., Penninger J.M. RANKL-RANK signaling in osteoclastogenesis and bone disease. Trends Mol Med 2006, 12:17-25.
56. Wang F.S., Yang K.D., Chen R.F., Wang C.J., Sheen-Chen S.M. Extracorporeal shock wave promotes growth and differentiation of bone-marrow stromal cells towards osteoprogenitors associated with induction of TGF-beta1. J Bone Joint Surg Br 2002, 84:457-461.
57. Wang C.J., Wang F.S., Yang K.D., Weng L.H., Hsu C.C., Huang C.S., Yang L.C. Shock wave therapy induces neovascularization at the tendon-bone junction. A study in rabbits. J Orthop Res 2003, 21:984-989.
58. Wood W.I., Cachianes G., Henzel W.J., Winslow G.A., Spencer S.A., Hellmiss R., Martin J.L., Baxter R.C. Cloning and expression of the growth hormone-dependent insulin-like growth factor-binding protein. Mol Endocrinol 1988, 2:1176-1185.
59. Yakar S., Liu J.L., Stannard B., Butler A., Accili D., Sauer B., LeRoith D. Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A 1999, 96:7324-7329.
60. Zhu J.F., Zhang X.L., Wang C.T., Zhang X.L., Peng X.C., Bai X.L. Human osteoblasts response to different magnitudes of mechanical stimulation in vitro. Zhonghua Wai Ke Za Zhi 2009, 47:381-384.